Clinical Trial Update: Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating iron isomaltoside for treating anemia in patients undergoing peritoneal dialysis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• Iron isomaltoside (iron isomaltoside)

Snippet

Sponsor: Xie Jingyuan, MD | Conditions: Renal Anemia, Peritoneal Dialysis (PD) | Phase 4 | Status: NOT_YET_RECRUITING